(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -16.11%-544.97K | 33.69%-241.79K | 32.29%-1.38M | 39.63%-233.82K | 46.62%-312.71K | 6.48%-469.37K | 35.35%-364.62K | -36.07%-2.04M | -19.32%-387.34K | 0.39%-585.81K |
Net income from continuing operations | -114.85%-901.22K | -54.39%-501.43K | -211.97%-6M | -1,619.39%-4.86M | 23.70%-398.17K | 36.89%-419.47K | 28.47%-324.79K | 16.48%-1.92M | 64.27%-282.48K | 23.72%-521.84K |
Operating gains losses | -1.44%12.21K | -50.40%18.32K | 138.45%67.33K | 79.56%-15.04K | 260.72%33.04K | 617.37%12.39K | 146.98%36.93K | -553.16%-175.12K | 16.60%-73.55K | ---20.56K |
Depreciation and amortization | -85.80%1.7K | -76.67%1.7K | 598.68%47.62K | 158.45%4.4K | 1,302.82%23.9K | 604.40%12K | 328.89%7.3K | 50.04%6.82K | 0.06%1.7K | 0.00%1.7K |
Asset impairment expenditure | ---62.1K | ---58.38K | --4.38M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Remuneration paid in stock | --81.69K | --115.59K | --0 | --0 | --0 | --0 | --0 | -41.68%291.6K | -97.75%7.6K | 67.65%57K |
Deferred tax | --0 | --0 | ---- | ---- | ---- | ---13.77K | ---26.19K | ---- | ---- | ---- |
Other non cashItems | 1,286.95%322.95K | -714.66%-142.77K | 860.84%264.93K | 1,332.68%160.57K | 541.21%57.85K | 558.46%23.29K | 744.48%23.23K | -111.82%-34.82K | -203.85%-13.03K | -206.71%-13.11K |
Change In working capital | 99.75%-207 | 500.94%325.18K | 29.49%-144.14K | 426.36%90.06K | 22.14%-69.3K | -183.34%-83.8K | 56.95%-81.1K | -173.75%-204.43K | -112.62%-27.6K | -43.10%-89K |
-Change in receivables | --0 | 144.12%9.66K | 121.29%7.77K | 381.91%102.82K | ---35.74K | ---37.41K | ---21.91K | ---36.47K | ---36.47K | --0 |
-Change in prepaid assets | 169.46%44.11K | 80.12%-4.53K | -494.94%-153.77K | -168.91%-62.19K | -105.30%-5.33K | -21.55%-63.5K | 77.16%-22.76K | -38.22%38.94K | 45.05%90.24K | 217.97%100.59K |
-Change in payables and accrued expense | -359.07%-44.31K | 978.34%320.04K | 100.90%1.87K | 160.75%49.42K | 85.11%-28.23K | -88.81%17.11K | 58.94%-36.44K | -196.61%-206.89K | -151.99%-81.36K | -921.67%-189.58K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -16.11%-544.97K | 33.69%-241.79K | 32.29%-1.38M | 39.63%-233.82K | 46.62%-312.71K | 6.48%-469.37K | 35.35%-364.62K | -36.07%-2.04M | -19.32%-387.34K | 0.39%-585.81K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -202.79%-1.64M | 97.55%-26.7K | -134.50%-3.85M | -107.15%-5.64K | -44.14%-2.22M | -733.62%-540.66K | -825.34%-1.09M | -61.99%-1.64M | 123.03%78.86K | -2,680.25%-1.54M |
Net PPE purchase and sale | -168.89%-1.67M | 94.90%-56.1K | -102.75%-3.96M | 58.43%-11.32K | -37.86%-2.22M | -227.98%-622.15K | -802.30%-1.1M | -287.80%-1.95M | 85.16%-27.23K | -628.11%-1.61M |
Net intangibles purchas and sale | --18.1K | --16.94K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net business purchase and sale | ---- | ---- | -72.83%73.56K | --0 | --0 | ---- | ---- | 151.09%270.74K | 156.36%92.42K | ---- |
Interest received (cash flow from investment activities) | 123.51%17.73K | 3.57%12.47K | -20.94%29.71K | -58.45%5.68K | -70.54%4.06K | 37.17%7.93K | 177.48%12.04K | 102.57%37.59K | 170.43%13.67K | 171.73%13.79K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -202.79%-1.64M | 97.55%-26.7K | -134.50%-3.85M | -107.15%-5.64K | -44.14%-2.22M | -733.62%-540.66K | -825.34%-1.09M | -61.99%-1.64M | 123.03%78.86K | -2,680.25%-1.54M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 401.57%2.5M | -100.22%-2.19K | 57.61%4.44M | 9,527.15%497.28K | 115,234.76%2.45M | -82.39%497.98K | 47,036.74%997.88K | 38.77%2.82M | -11.66%-5.28K | -100.21%-2.13K |
Net issuance payments of debt | 401.08%2.5M | -100.18%-1.75K | 85,626.26%4.44M | 33,710.06%497.77K | 169,531.90%2.45M | 56,947.32%498.55K | 71,830.03%998.48K | -46.26%-5.2K | -9.14%-1.48K | -85.73%-1.45K |
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 47.74%2.83M | -21.20%-3.15K | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | 30.99%-392 | 27.68%-439 | 20.98%-2.18K | 25.00%-483 | 22.76%-526 | 19.43%-568 | 17.30%-607 | -30.69%-2.76K | 16.15%-644 | 49.44%-681 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 401.57%2.5M | -100.22%-2.19K | 57.61%4.44M | 9,527.15%497.28K | 115,234.76%2.45M | -82.39%497.98K | 47,036.74%997.88K | 38.77%2.82M | -11.66%-5.28K | -100.21%-2.13K |
Net cash flow | ||||||||||
Beginning cash position | -77.79%173.41K | -64.22%442.52K | -41.16%1.24M | -87.98%186.34K | -92.73%267.44K | -44.94%780.84K | -41.16%1.24M | -18.68%2.1M | -44.10%1.55M | 53.18%3.68M |
Current changes in cash | 161.66%315.74K | 40.52%-270.67K | 8.20%-794.21K | 182.17%257.82K | 96.01%-84.94K | -122.65%-512.04K | 33.44%-455.06K | -79.17%-865.14K | 53.29%-313.76K | -671.73%-2.13M |
Effect of exchange rate changes | 2,215.44%28.77K | 287.31%1.56K | ---- | ---- | --3.83K | ---1.36K | ---835 | ---- | ---- | --0 |
End cash Position | 93.66%517.92K | -77.79%173.41K | -64.22%442.52K | -64.22%442.52K | -87.98%186.34K | -92.73%267.44K | -44.94%780.84K | -41.16%1.24M | -41.16%1.24M | -44.10%1.55M |
Free cash from | -103.19%-2.22M | 79.67%-297.89K | -33.76%-5.34M | 40.87%-245.14K | -15.36%-2.54M | -57.83%-1.09M | -113.57%-1.46M | -99.37%-3.99M | 18.41%-414.57K | -678.11%-2.2M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data